These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 13985260)

  • 1. [Pyrazinamide in association with streptomycin, PAS and isoniazid in the therapy of pulmonary tuberculosis].
    TODOROFF T; FRANZOSI P
    Minerva Med; 1962 Sep; 53():2667-73. PubMed ID: 13985260
    [No Abstract]   [Full Text] [Related]  

  • 2. [FURTHER CONTRIBUTIONS TO THE DRUG THERAPY OF AN ADULT TYPE OF PULMONARY TUBERCULOSIS IN ADOLESCENTS ISONIAZID PLUS PYRAZINAMIDE THERAPY].
    GOERGENYI O; SZOCSKA M
    Tuberk Tudobetegsegek; 1963; 16():100-5. PubMed ID: 14054909
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON HEPATITIS IN PULMONARY TUBERCULOSIS PATIENTS].
    ZADOR A; NAGY G; GEVICSER P; KLIMENKO O
    Tuberk Tudobetegsegek; 1963; 16():147-9. PubMed ID: 14054916
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparison of 3 antitubercular therapeutic programs comprising isoniazid with 4,4'-diisoamyloxythiocarbanilide. streptomycin and calcium-benzoyl-PAS].
    FAVEZ G; VULLIEMOZ P; BREAUD P
    Acta Tuberc Pneumol Belg; 1963; 54():103-9. PubMed ID: 14010281
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our region's possibilities in the ambulatory treatment of pulmonary tuberculosis with the biweekly administration of a perfused triple combination of isoniazid, streptomycin and PAS].
    Burghard G; Petitjean R; Scherrer B; Schranz J
    Rev Tuberc Pneumol (Paris); 1970; 34(5):662-3. PubMed ID: 5496786
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mechanism of action and effectiveness of intravenous administration of tubazid, streptomycin and PAS in the therapy of pulmonary tuberculosis].
    Pilipchuk NS; Ivaniuota OM; Kovalenko NN
    Probl Tuberk; 1970; 48(1):26-30. PubMed ID: 5425441
    [No Abstract]   [Full Text] [Related]  

  • 8. Streptomycin plus pas plus pyrazinamide in the retreatment of pulmonary tuberculosis in East Africa.
    East Afr Med J; 1972 Jan; 49(1):7-15. PubMed ID: 4555041
    [No Abstract]   [Full Text] [Related]  

  • 9. COMBINED DRUG THERAPY OF PULMONARY TUBERCULOSIS.
    BOESZOERMENYI M; FAUSZT I; KANITZ E; SCHWEIGER O
    Ther Hung; 1963; 12():9-14. PubMed ID: 14059821
    [No Abstract]   [Full Text] [Related]  

  • 10. [The function of the cardiovascular system in patients with pulmonary tuberculosis treated by intravenous administration of streptomycin, tubazid and PAS].
    Golanov VS
    Vrach Delo; 1969 Jun; 6():62-6. PubMed ID: 5821665
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative study (tolerance and effectiveness) of classic antituberculous therapy (P.A.S.-streptomycin-isoniazid) and a new combination (prothionamide-streptomycin-isoniazid)].
    Charpin J; Taranger J; Boutin C; Girbal JP
    Mars Med; 1969; 106(11):895-7. PubMed ID: 5407168
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacteriostatic concentration of tubazid, streptomycin and PAS in the blood of tuberculous patients in separate and combined administration of the drugs].
    Bibik NF
    Probl Tuberk; 1969; 47(4):58-62. PubMed ID: 5368447
    [No Abstract]   [Full Text] [Related]  

  • 13. [Directions for the treatment of children with primary pulmonary and hilar lymph node tuberculosis].
    van ZEBEN ; van der DRIFT
    Maandschr Kindergeneeskd; 1963 Jan; 31():3-25. PubMed ID: 14003349
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
    Romano S; Grella G
    Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
    [No Abstract]   [Full Text] [Related]  

  • 15. [CONTROLLED TUBERCULOSTATIC THERAPY IN PREVIOUSLY UNTREATED TUBERCULOSIS].
    SABLJICA B; RAJCEVIC V
    Tuberkulosearzt; 1963 Aug; 17():514-9. PubMed ID: 14057448
    [No Abstract]   [Full Text] [Related]  

  • 16. [Limits of ambulant therapy from the standpoint of hospital treatment].
    UEMURA T
    Kekkaku; 1962 Aug; 37():429-32. PubMed ID: 13995188
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the drug resistance of Myc. tuberculosis isolated from patients with primary pulmonary tuberculosis. Bacteriological and clinical observations].
    ZORZOLI P; MONCALVO F
    G Ital Tuberc Mal Torace; 1962; 16():219-passim. PubMed ID: 14003952
    [No Abstract]   [Full Text] [Related]  

  • 18. [Liver function during tuberculosis therapy with streptomycin, isoniazid and aminosalicylate].
    Aamodt T
    Nord Med; 1970 Jun; 83(24):774. PubMed ID: 5426083
    [No Abstract]   [Full Text] [Related]  

  • 19. SOME OBSERVATIONS IN RELATION TO PROPERDIN SYSTEM. III. RELATION BETWEEN SERUM PROPERDIN LEVEL AND ANTI-TUBERCULOUS DRUG THERAPY IN HUMAN PULMONARY TUBERCULOSIS.
    MAJUMDAR AC; SEN R; MATHUR PD
    Ann Biochem Exp Med; 1963 Aug; 23():305-8. PubMed ID: 14060049
    [No Abstract]   [Full Text] [Related]  

  • 20. [OUR EXPERIENCE WITH THE TREATMENT OF PULMONARY TUBERCULOSIS RESISTANT TO CLASSICAL TUBERCULOSTATIC DRUGS].
    KOVACEVIC M; MILUTINOVIC R; KONJOVIC M; ZIGIC M
    Tuberkuloza; 1963; 15():250-3. PubMed ID: 14067279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.